Dr Jamie Mills

Dr Jamie Mills is a distinguished consultant clinical oncologist renowned for his expertise in the diagnosis and treatment of colorectal and anal cancers, alongside prostate cancer and bladder cancers, using stereotactic ablative body radiotherapy (SAB), including oligometastatic disease, specialised radiotherapy, immunotherapy, chemotherapy, and hormonal therapy.

Dr Mills successfully completed an MB ChB at the University of Leicester in 2000, followed by specialised training in oncology. His postgraduate education included rigorous residency and fellowship programmes at leading medical institutions throughout the UK, where he honed his skills in oncology and gained comprehensive knowledge of cancer biology, radiotherapy, and chemotherapy.

His education also included advanced training in innovative cancer treatment techniques and patient-centred care. Dr Mills is actively involved in oncological research, contributing to numerous studies and publications that advance the understanding and treatment of cancer. His main research interests include the development of novel therapeutic approaches, optimising radiation therapy protocols, and exploring the molecular underpinnings of cancer.

Dr Mills, to date, has published extensively in peer-reviewed journals, presenting his findings at national and international conferences. He is also a member of several professional organizations, including the American Society of Clinical Oncology (ASCO) and the European Society for Medical Oncology (ESMO). These affiliations keep him at the forefront of oncological advancements and provide him with a platform to collaborate with peers and contribute to the ongoing development of cancer treatments.